THBS1 and coronary artery disorder: We showed that gene expression of THBS-1, an inhibitor of angiogenesis through the direct effects on endothelial cell migration, proliferation, survival and apoptosis as well as by antagonizing the activity of VEGF [43], is significantly increased in ADSC from patients with CAD and CAD + T2DM.